GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 24 filers reported holding GALMED PHARMACEUTICALS LTD in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $16,000 | -23.8% | 50,789 | +60.7% | 0.00% | – |
| Q2 2022 | $21,000 | -89.9% | 31,600 | -47.9% | 0.00% | – |
| Q1 2021 | $208,000 | -42.2% | 60,700 | -47.6% | 0.00% | – |
| Q4 2020 | $360,000 | +197.5% | 115,800 | +238.2% | 0.00% | – |
| Q3 2020 | $121,000 | -67.6% | 34,242 | -56.1% | 0.00% | – |
| Q2 2020 | $373,000 | +168.3% | 78,004 | +94.5% | 0.00% | – |
| Q1 2020 | $139,000 | -62.9% | 40,100 | -38.2% | 0.00% | – |
| Q4 2019 | $375,000 | +374.7% | 64,908 | +293.4% | 0.00% | – |
| Q3 2019 | $79,000 | -66.7% | 16,499 | -48.9% | 0.00% | – |
| Q2 2019 | $237,000 | -11.6% | 32,300 | -1.5% | 0.00% | – |
| Q1 2019 | $268,000 | +17.0% | 32,800 | -2.4% | 0.00% | – |
| Q4 2018 | $229,000 | -54.2% | 33,600 | -62.5% | 0.00% | – |
| Q2 2018 | $500,000 | 0.0% | 89,705 | 0.0% | 0.00% | -100.0% |
| Q1 2018 | $500,000 | +44.9% | 89,705 | +137.9% | 0.00% | – |
| Q4 2017 | $345,000 | +604.1% | 37,705 | +245.9% | 0.00% | – |
| Q2 2016 | $49,000 | -55.0% | 10,900 | +0.9% | 0.00% | – |
| Q2 2015 | $109,000 | -31.4% | 10,800 | -36.1% | 0.00% | – |
| Q1 2015 | $159,000 | – | 16,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|